Merck & Co., Inc. (MRK) Stock Overview
NYSE · Healthcare · Drug Manufacturers - General
About Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair,…
Source: Yahoo Finance
Sector & Industry
Merck & Co., Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry group. It is listed on the NYSE exchange.
Merck & Co., Inc. at a Glance
| Company | Merck & Co., Inc. |
| Ticker | MRK |
| Exchange | NYSE |
| Currency | USD |
| Price | $127.50 |
| Market cap | $314.90B |
| P/E ratio (trailing) | 36.02 |
| EPS (trailing) | $3.54 |
| 52-week high | $131.74 |
| 52-week low | $76.66 |
| Dividend yield | 2.67% |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Employees | 73,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
What is Merck & Co., Inc.'s P/E ratio?
Merck & Co., Inc. (MRK) has a trailing P/E ratio of 36.02 as of our latest data snapshot.
What is Merck & Co., Inc.'s market cap?
Merck & Co., Inc.'s market capitalisation is $314.90B based on the most recent snapshot.
What is MRK's 52-week range?
Over the past 52 weeks, MRK has traded between $76.66 and $131.74.
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Related Healthcare Stocks
Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: